Page contents Back to list Full notification Final report General information GMO characterization European Commission administrative Information Return to search
Full notification Final report - General information Notification Number B/DE/22/PEI4743 Member State to which the notification was sent Germany Date of acknowledgement from the Member State Competent Authority 14/12/2021 Title of the Project A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENVĪ”30 [live, attenuated]) in Healthy Adults  Proposed period of release: 30/05/2022 to 31/01/2023 Name of the Institute(s) or Company(ies) Merck Sharp & Dohme Corp.
Is the same GMO been notified elsewhere by the same notifier? Yes:
Belgium; Germany; Finland;
Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: RNA Virus Identity of the GMO: Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Dengue Genus: Flavivirus Species: dengue virus (DENV) Subspecies: 4 Strains (DENV1, DENV2, DENV3, Strain: Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Not known
Close
Select your language
English